Anlon Healthcare Limited has filed its annual disclosure under Regulation 30(1), 30(2), and Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, for the financial year 2025-2026. The disclosure, dated April 01, 2026, was submitted to the listing departments of both BSE Limited and the National Stock Exchange of India Ltd. It was signed by Punitkumar Rasadia, Managing Director (DIN: 06696258), on behalf of all promoters of the company.

Key Declaration by Promoters

In the disclosure, the promoters and members of the promoter group formally declared that no encumbrance — direct or indirect — was created on shares of Anlon Healthcare Limited at any point during the financial year 2025-2026. This declaration is in compliance with the requirements set out under Regulation 31(4) of the SEBI Takeover Regulations, 2011, as amended.

Promoter and Promoter Group Members

The disclosure includes an Annexure listing all individuals and entities belonging to the promoter and promoter group of the company. The following table presents the complete list as submitted:

Filing Details

The disclosure was submitted to the stock exchanges in accordance with regulatory requirements. Key details of the filing are summarised below:

The filing confirms that all promoters and promoter group members of Anlon Healthcare Limited are in compliance with the annual disclosure requirements prescribed by SEBI under the Takeover Regulations for the financial year 2025-2026.

Anlon Healthcare Limited has announced a television interview of its Managing Director as part of its regulatory disclosure obligations to stock exchanges.

Interview Details

The company has scheduled a TV interview featuring Mr. Punitkumar Rasadia, Managing Director of Anlon Healthcare Limited, with NDTV Profit. The interview is set to take place on Monday, April 27, 2026, at 1:30 PM.

Regulatory Compliance

The announcement was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has notified both BSE Limited and The National Stock Exchange of India Limited about this scheduled media interaction.

Content Guidelines

Anlon Healthcare Limited has emphasized that the discussion during the interview will be based exclusively on publicly available information and documents. The company has specifically stated that no unpublished price-sensitive information (UPSI) is proposed to be discussed during the interaction, ensuring compliance with regulatory guidelines.

Contingency Provisions

The company has noted that the interview may be cancelled, rescheduled, or postponed due to exigencies on the part of both parties. This standard disclaimer provides flexibility for both the company and the media organization in case of unforeseen circumstances.

The formal communication was digitally signed by Managing Director Punitkumar Rasadia on April 27, 2026, at 12:34:27 hours, demonstrating the company's commitment to timely regulatory disclosures.